Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients
- PMID: 29100372
- PMCID: PMC5652766
- DOI: 10.18632/oncotarget.20356
Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients
Abstract
To explore the correlation of aspirin resistance (AR) with clinical stroke severity and infarct volume using diffusion-weighted imaging (DWI) in 224 Chinese ischemic stroke patients who were taking aspirin before stroke onset. In those patients, the median age was 64 years (IQR, 56-75 years), and males accounting for 54.9%(123)of the total subjects. Fifty of 224 enrolled patients (22.3%; 95% confidence interval (CI), 16.9% to 27.7%) showed AR. In the median regression model, significant increase was estimated in NIHSS score of 0.04 point for every 1-point increase in aspirin reaction units (ARU) (95% CI, 0.02 to 0.06; P<0.001). Diffusion-weighted MRI (DWI)-measured infarct volume were significantly higher in patients with AR as compared with those with AS [13.21 (interquartile ranges [IQR], 8.51-23.88) vs.4.26 (IQR, 1.74-11.62); P<0.001). Furthermore, a statistically significant increase was also measured in NIHSS score of 0.05 point for every 1-point increase in ARU in the median regression model (95% CI, 0.03 to 0.08; P<0.001). The median DWI infarct volume was significantly larger in the highest ARU quartile when compared to that in the low 3 quartiles (P<0.001). In conclusion, stroke patients with AR indicated higher risk of severe strokes and large infarcts compared to patients in the aspirin-sensitive group.
Keywords: aspirin resistance; diffusion-weighted imaging; infarct volume; stroke severity.
Conflict of interest statement
CONFLICTS OF INTEREST On behalf of all authors, the corresponding author states that there is no conflicts of interest.
Figures


Similar articles
-
Aspirin resistance is associated with increased stroke severity and infarct volume.Neurology. 2016 May 10;86(19):1808-17. doi: 10.1212/WNL.0000000000002657. Epub 2016 Apr 8. Neurology. 2016. PMID: 27060166
-
Association of aspirin resistance with increased stroke severity and infarct size.JAMA Neurol. 2013 Feb;70(2):208-13. doi: 10.1001/jamaneurol.2013.601. JAMA Neurol. 2013. PMID: 23165316
-
Aspirin resistance predicts unfavorable functional outcome in acute ischemic stroke patients.Brain Res Bull. 2018 Sep;142:176-182. doi: 10.1016/j.brainresbull.2018.07.004. Epub 2018 Jul 24. Brain Res Bull. 2018. PMID: 30016728
-
Association of Bun/Cr ratio-based dehydration status with infarct volumes and stroke severity in acute ischemic stroke.Clin Neurol Neurosurg. 2023 Jun;229:107741. doi: 10.1016/j.clineuro.2023.107741. Epub 2023 Apr 26. Clin Neurol Neurosurg. 2023. PMID: 37119656
-
Aspirin resistance are associated with long-term recurrent stroke events after ischaemic stroke.Brain Res Bull. 2017 Sep;134:205-210. doi: 10.1016/j.brainresbull.2017.08.012. Epub 2017 Aug 24. Brain Res Bull. 2017. PMID: 28842303
Cited by
-
Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.Front Neurol. 2021 Jun 10;12:667234. doi: 10.3389/fneur.2021.667234. eCollection 2021. Front Neurol. 2021. PMID: 34177775 Free PMC article. Review.
-
Unfavorable Dynamics of Platelet Reactivity during Clopidogrel Treatment Predict Severe Course and Poor Clinical Outcome of Ischemic Stroke.Brain Sci. 2021 Feb 18;11(2):257. doi: 10.3390/brainsci11020257. Brain Sci. 2021. PMID: 33670712 Free PMC article.
-
Unfavorable Changes of Platelet Reactivity on Clopidogrel Therapy Assessed by Impedance Aggregometry Affect a Larger Volume of Acute Ischemic Lesions in Stroke.Diagnostics (Basel). 2021 Feb 27;11(3):405. doi: 10.3390/diagnostics11030405. Diagnostics (Basel). 2021. PMID: 33673437 Free PMC article.
-
Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke.Front Pharmacol. 2020 Sep 25;11:580783. doi: 10.3389/fphar.2020.580783. eCollection 2020. Front Pharmacol. 2020. PMID: 33101034 Free PMC article.
-
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.BMC Neurol. 2024 Mar 1;24(1):81. doi: 10.1186/s12883-024-03585-4. BMC Neurol. 2024. PMID: 38429754 Free PMC article. Clinical Trial.
References
-
- Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014;45:3754–832. - PMC - PubMed
-
- Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003;41:961–5. - PubMed
-
- Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlboeck M, Schreiner W, Losert U, Wolner E. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost. 1997;78:1003–7. - PubMed
-
- Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation. 2002;105:1650–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials